Objectives: To assess the medication adherence rates and quality of life in Rheumatoid Arthritis (RA) patients. MethOds: RA patients admitted in the general medicine ward of a tertiary care hospital in Karnataka, India, during August to December 2013 were enrolled in the study. Demographic data of these patients was collected from patients' medical records, outpatient data and by interviews. Patients (age≥ 18 years) with RA, irrespective of sex, fulfilling the 2010 ACR/EULAR Classification Criteria, were enrolled in the study. Patient's assessment of adherence to medication was analyzed by using Medication Adherence Report Scale (MARS) and physical function using the Kannada version of the Stanford Improved Health Assessment Questionnaire (KA-HAQ) was collected. Results: The mean age of 72 RA patients was 46.90 ± 12.88 years and disease durations was 4.27 ± 5.53 years. 86% of the patients were females. Among patients, 15 (21.43%) received methotrexate alone and 28 (40%) received a combination therapy of methotrexate and hydroxychloroquine. The mean KA-HAQ score of RA patients measured by KA-HAQ was 2.70 ± 1.01. Scores on MARS ranged from 26 to 41 with a mean score of 38.65 ± 3.5. The Cronbach's alpha for the MARS was 0.6 and KA-HAQ was 0.92.Using the mean cut-point 44% of 68 patients who completed the MARS were adherent and remaining 64% were not adherent. cOnclusiOns: In our study we found that 64% of the patients were not adherent to the medications which lead to decreased quality of life RA patients. Adherence to the medications is the optimal management for RA. Objectives: Purpose of the study was to determine kinematic difference between overground and treadmill walking. MethOds: A total of 30 healthy men, 30 healthy female aged 19-23 participated in the study. Inclusion criteria in the study were that participants no low back and lower extremity pain, no traumatic injury and foot deformities. Participants walked at their preferred velocity on overground. The treadmill velocity was adjusted average velocity obtained in overground walking. Walking in two conditions was captured by high speed camera and analyzed by motion analyses software. Results: In comparison between treadmill and overground walking was significantly different. Maximum hip flexion angle (P< 0.017), maximum),maximum knee flexion (0.033) maximum ankle dorsiflexion (P< 0.028) and maximum ankle planterflexion (P< 0.044) were significantly different in the two conditions. In the male, maximum hip flexion (P< 0.020), maximum knee flexion (P< 0.019), maximum ankle dorsiflexion (P< 0.018) ) were significantly different in the two conditions. For female, maximum hip flexion (P< 0.015), maximumankle dorsiflexion (P< 0.045), maximum plan terflexion (P< 0.021) were significantly different in the two conditions. Overground walking male of knee extension was associated with body mass (r= -411, p< 0.05), hip flexion was associated with body height (r= 0.433, p< 0.05). Overground walking female of knee flexion was associated with body mass during (r= 0.469, p< 0.05), ankle dorsiflexion was associated with height (r= 0.443, p< 0.05). Treadmill walking in female, hip extension (r= -0.542, p< 0.05), knee flexion (r= -0.342, p< 0.05), ankle dorsiflexion (r= -0.469, p< 0.05) was associated with body mass.Hip extension was associated with height (r= -0.542, p< 0.05). cOnclusiOns: The study revealed significantly kinematic difference between overground and treadmill walking. Objectives: Patellofemoral pain syndrom is a common problem experienced by active adults and adolescents. Ascending stairs is one of the most painful activities of daily living in person with patellofermoral pain syndrome. However, its etiology has remained vague and is controversial. Nevertheless previous studies were reported from either the viewpoint of kinematics of the knee joint or hip muscle weakness, and is unclear whether hip and knee muscle weakness affect on knee medial displacement during physical acitvities. of the this study was to determine relationship between hip muscle strength and kinematics of the knee joint. MethOds: Forty healthy subjects participated in this study. The knee medial displacement was measured during a functional tests using two high speed cameras. Images of videos were processed using motion analysis software. Peak isometric muscle strengths of the following muscles were measured hip abductors, hip adductors, hip external rotators, hip internal rotators, knee extensors and knee flexors. Hip and knee muscle strengths were measured using a hand held dynamometer as isometric muscle strength referring to Katoh's method. Results: Muscle strength of hip external rotators was associated with knee medial displacement during both single leg squatting (r= -0.519, P< 0.001) and dropping (r= -0.520, P< 0.001). cOnclusiOns: The present results suggest that hip muscles' strength, particularly hip external rotators' strength are closely associated with knee medial displacement.
Objectives: Purpose of the study was to determine kinematic difference between overground and treadmill walking. MethOds: A total of 30 healthy men, 30 healthy female aged 19-23 participated in the study. Inclusion criteria in the study were that participants no low back and lower extremity pain, no traumatic injury and foot deformities. Participants walked at their preferred velocity on overground. The treadmill velocity was adjusted average velocity obtained in overground walking. Walking in two conditions was captured by high speed camera and analyzed by motion analyses software. Results: In comparison between treadmill and overground walking was significantly different. Maximum hip flexion angle (P< 0.017), maximum),maximum knee flexion (0.033) maximum ankle dorsiflexion (P< 0.028) and maximum ankle planterflexion (P< 0.044) were significantly different in the two conditions. In the male, maximum hip flexion (P< 0.020), maximum knee flexion (P< 0.019), maximum ankle dorsiflexion (P< 0.018) ) were significantly different in the two conditions. For female, maximum hip flexion (P< 0.015), maximumankle dorsiflexion (P< 0.045), maximum plan terflexion (P< 0.021) were significantly different in the two conditions. Overground walking male of knee extension was associated with body mass (r= -411, p< 0.05), hip flexion was associated with body height (r= 0.433, p< 0.05). Overground walking female of knee flexion was associated with body mass during (r= 0.469, p< 0.05), ankle dorsiflexion was associated with height (r= 0.443, p< 0.05). Treadmill walking in female, hip extension (r= -0.542, p< 0.05), knee flexion (r= -0.342, p< 0.05), ankle dorsiflexion (r= -0.469, p< 0.05) was associated with body mass.Hip extension was associated with height (r= -0.542, p< 0.05). cOnclusiOns: The study revealed significantly kinematic difference between overground and treadmill walking. Objectives: Patellofemoral pain syndrom is a common problem experienced by active adults and adolescents. Ascending stairs is one of the most painful activities of daily living in person with patellofermoral pain syndrome. However, its etiology has remained vague and is controversial. Nevertheless previous studies were reported from either the viewpoint of kinematics of the knee joint or hip muscle weakness, and is unclear whether hip and knee muscle weakness affect on knee medial displacement during physical acitvities. of the this study was to determine relationship between hip muscle strength and kinematics of the knee joint. MethOds: Forty healthy subjects participated in this study. The knee medial displacement was measured during a functional tests using two high speed cameras. Images of videos were processed using motion analysis software. Peak isometric muscle strengths of the following muscles were measured hip abductors, hip adductors, hip external rotators, hip internal rotators, knee extensors and knee flexors. Hip and knee muscle strengths were measured using a hand held dynamometer as isometric muscle strength referring to Katoh's method. Results: Muscle strength of hip external rotators was associated with knee medial displacement during both single leg squatting (r= -0.519, P< 0.001) and dropping (r= -0.520, P< 0.001). cOnclusiOns: The present results suggest that hip muscles' strength, particularly hip external rotators' strength are closely associated with knee medial displacement.
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Objectives:
A phase III clinical trial demonstrated the advantage of denosumab over zoledronic acid(ZA) in delaying the first on-study and subsequent skeletalrelated events(SREs) in patients with prostate cancer(PC). Recently, generic ZA became available. The purpose of this study was to examine the cost-effectiveness of denosumab vs. brand or generic ZA in the prevention of SREs in Kazakhstani patients with PC. MethOds: An excel-based Markov model was constructed with 4-week model cycles to analyse the cost-effectiveness of the treatments from the perspective of Ministry of Health with a 10-year time horison for PC cohort. Direct costs(in 2014 tenge) included costs of drug, adverse event and SRE(pathologic fracture, surgery to bone, radiation to bone, spinal cord compression) treatment. A discount rate of 3% per year was applied. Effectiveness was appraised based on the number of SREs. The health states were defined according to SRE occurance,SRE history and death. The model assumed that a maximum of 1 SRE could occur in each cycle. Transition probabilities were derived from the relevant phase III trials. Results were present in the incremental total cost per SRE avoided. One-way sensitivity analyses were performed to examine the robustness of the model. Results: Over 10-year period, denosumab incurred 103091 tenge higher costs than brand ZA, 677133 tenge higher costs than generic ZA, 0.58 fewer SREs per PC patient; The estimated incremental total direct costs per SRE avoided with the use of denosumab were 177743 tenge (instead of brand ZA) and 1167470 tenge (instead of generic ZA). Results were robust to one-way sensitivity analyses. cOnclusiOns: With assumption that brand and generic ZAs are equally effective, denosumab seems to be superior alternative for brand ZA (insignificant difference in costs), and costly alternative for generic ZA from a perspective of Ministry of Health of Republic of Kazakhstan. Objectives: To evaluate the cost-utility of Infliximab plus methotrexate (MTX) compared with MTX alone, in severe rheumatoid arthritis (RA) patients who were intolerant or inadequately responded to conventional DMARDs including MTX which is available in the national list of essential medicine (NLEM) in Thailand. MethOds: A Markov model consisting of Markov states defined by the disease activity score 28 (DAS28) was developed to reflect the clinical assessment in the treatment of RA in Thailand. Markov states for remission (DAS < 2.6), low disease activity (DAS 2.6-3.2), moderate disease activity (DAS 3.2-5.1), high disease activity (DAS ≥ 5.1), and dead were defined. With a cycle length of 6 months, transition probabilities were estimated based on ACR response in the clinical trial which was assumed to directly represent changes in disease severity. DAS28 was assumed to be a clinically appropriate proxy for utility estimation (EQ5D). Both direct and indirect costs including patient's income loss were calculated under societal perspective. Data source of resource use are mainly based on estimation by experts. Cost and outcomes were discounted at 3%. One-way and probabilistic sensitivity analysis were conducted to test the robustness of the results. Results: Infliximab plus MTX had an ICER of 131,867 baht per QALY gained compared to MTX alone. This falls into the range of acceptable ICER within 1-3 times of GDP per capita in Thailand (120,000 -360,000 baht per QALY gained). The probability of cost-effective for Infliximab was presented at 8%, 50%, and 70% at the willingness-to-pay of 120,000 baht, 240,000 baht, and 360,000 baht per QALY gained respectively. cOnclusiOns: This model suggests, with its underlying assumption, that Infliximab plus MTX seems to be more costeffective treatment than MTX alone for Thai patients with severe RA that cannot be controlled by conventional DMARDs. Objectives: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and destruction of the joints often resulting in a significant impact on quality of life. There are limited studies estimating the resource utilization of RA patients using real-world data in Taiwan. This study aimed to estimate the direct health care utilization in Taiwanese RA patients. MethOds: We performed a retrospective database analysis using 2011 data from the National Health Insurance Research Database (NHIRD) in Taiwan, a claims-based database covering over 99% of the population. We estimated the annual incremental health care utilization of RA patients compared with a control cohort matched 1:4 on demographics and clinical covariates. Health care resources were evaluated for the following categories: surgeries, medications, ward use, medical materials and devices (MMDs), and lab tests. The percentage of patients partaking in a health care utilization category was calculated as the number of patients with the specific claim divided by the total number of patients in the cohort. Results: The total number of RA patients was 41,269. Females made up 78% of the cohort and the mean age was 59.4 years (SD= 15.5). The average history of RA was 5.6 years (SD= 2.7). When comparing RA to non-RA patients, drug utilization had some of the largest differences. RA patients had used traditional disease-modifying antirheumatic drugs (TDMARDs), biologic DMARDs (BDMARDs), NSAIDs, and steroids at a rate of 70.8%, 13.2%, 64.8% and 52.8% respectively. For surgeries, lab tests, and MMDs, the highest incremental differences were cataract surgeries, immunology examination, and orthopedic replacements. cOnclusiOns: Direct health care utilization of RA was substantial in Taiwan. The NHIRD provides a comprehensive source for estimating the incremental resource utilization of RA versus non-RA patients. This study provides a key piece of information to estimate the burden of the RA illness in Taiwan. tion. cOnclusiOns: The dimensions excluding Ability of act all had the higher sensitivity on AIMS2-2F scale, which means overall sensitivity was better than SF-6D . Therefore, EQ-5D is more suitable for the evaluation of the QOL of patients with osteoarthritis. But the Psychological health dimension of SF-6D showed strong sensitivity, which prompts us Psychological problems are the important factors influencing the Osteoarthritis patients life quality. Objectives: Biologic treatments have improved outcome for immunology diseases in the last decades globally. However, biologic penetration in China is lower compared to developed countries. This study aims to explore the willingness-to-pay (WTP) for biologics in immunology diseases in China by understanding decisions driving physicians' prescribing behavior and patients' payment. MethOds: Primary market research was done by interviewing 160 physicians with biologic experience, 200 patients consisting of patients who have not received any biologic treatments before (bio-naïve), and patients with biologic experience (bio-experienced) from large hospitals (tier 3A) in Tier 1 and 2 cities. Patients were recruited with a diverse set of affordability as measured by household incomes. Results: The results show that patients rely on physicians for treatment recommendation. For rheumatoid arthritis, ankylosing spondylitis, and psoriasis, the top four factors driving physician's recommendation are drug cost, patients' ability-to-pay, safety of treatment and efficacy of treatment. For Ulcerative Colitis (UC) and Crohn's Disease (CD), the top four factors were safety, efficacy, patients' affordability followed by drug cost. The difference in pattern for UC and CD is likely attributed to the more severe nature of these diseases. Other factors such as injection frequency and mode of administration ranked lower for all indicators. cOnclusiOns: Patients interview results show that ≈60% of bio-naïve patients were rejected biologic treatment due to cost; ≈30% of bio-experienced patients stopped biologic treatments due to cost. This confirms that affordability considerations do limit the potential benefit that biologic treatments can provide. Interestingly, ≈30% of bio-experienced patients have stopped biologic treatment as it was perceived that treatment course was completed. This could be attributed to how physicians perceive biologics to be used. While affordability limits biologic penetration in auto-immune diseases in China, there are other considerations e.g. the severity of diseases and physician perception of treatment paradigm. Objectives: Use of innovative medicines in oncology and immunology is relatively lower in China compared to developed countries. This study aims to explore the willingness-to-pay (WTP) for these two therapeutic areas by understanding decisions driving physicians' prescribing behavior and patients' payment in immune diseases (rheumatoid arthritis, ankylosing spondylitis, and psoriasis) and oncology (prostate cancer). MethOds: For immunology, primary market research was done by interviewing 160 physicians with biologic experience, 200 patients consisting of patients who have not received any biologic treatments before (bio-naïve), and patients with biologic experience (bio-experienced). For oncology, 50 physicians and 40 patients were recruited. All physicians and patients were recruited from large hospitals (tier 3A) from Tier 1, 2 cities. Patients were recruited to represent a diverse set of affordability. Results: The results show that patients rely on physicians for treatment recommendation. For rheumatoid arthritis, ankylosing spondylitis, and psoriasis, the top four factors driving physician's recommendation are drug cost, patients' abilityto-pay, safety of treatment and efficacy of treatment. For Ulcerative Colitis (UC) and Crohn's Disease (CD), the top four factors were safety, efficacy, patients' affordability followed by drug cost. The difference in pattern for UC and CD is likely attributed to the more severe nature of these diseases. Other factors such as injection frequency and mode of administration ranked lower for all indicators. For oncology, the top factors driving physician prescription are efficacy (overall survival, progression-free survival) followed by safety and tolerability. Patient affordability and drug cost are ranked much lower. Similarly, from patients interview results, efficacy was rated more important than cost as a factor driving willingness-to-pay. cOnclusiOns: Observations from these two therapy areas show that cost and affordability are the top considerations when the diseases are less severe. For severe diseases and lifethreatening diseases, efficacy and safety of the drug are rated more than drug cost. 'an, Xi'an, China, 2 Xi'an Jiaotong University Health Science Center, xi'an, China, 3 The Fifth Hospital of Xi 'an, Xi'an, China Objectives: To observe the clinical efficacy and economic value of Qin Xi-tong(QXT) during the long-term treatment for patients of RA. MethOds: Caulis Sinomenii(CS) has been recognized as an effective medicinal plant for arthritis. The Fifth Hospital of Xi'an developed water extract from CS to a novel kind of drug naming QXT. RA was diagnosed in 200 patients referred to Department of Rheumatology. All the patients were classified according to their different areas. They were respectively evaluated by the score of VAS, DAS28 and the response rates of ACR20/70 .We also follow up the patients for the usage rate, treatment compliance and satisfaction of QXT. We count the cost of patients and the income of self-made chinese traditional medicine in our hospital to measure the economic value of QXT. Results: We found that: 1) There were 140 out of 200 patients who were from 14 provinces of China with RA using QXT.2. Percentage of the satisfaction and compliance with the treatment of QXT+MTX group were higher than MTX group, satisfaction rates (94.2% vs. 67.1%, X 2 = 11.7, P< 0.01) ,compliance rates (91.4% vs. 62.9%, X 2 = 16.2, P< 0.01) , respectively. 3)statistical result of year 2 showed : Compared with pretherapy,QXT+ MTX group scored significantly lower of VAS, while achieving higher level of ACR20 and ACR70 . 4)QXT was safe and well tolerated in this trial, difference of adverse events was not statistically significant. 5)The statistics showed the mean cost for QXT only occupied 9.2%(78/856)of patient's expenses for the treatment of RA. cOnclusiOns: It is the first time to study the economic value of QXT in a randomized clinical trial for 2 years. QXT+MTX could contribute to the higher clinical remission rates of patients with RA. It is worth noting that Chinese patients with RA was much better satisfied and complying with QXT which is actually consistent with our clinical practice.
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care neeDs for rheuMatoiD arthritis froM Patient PersPectives: a qualitative stuDy froM singaPore general hosPital Xin X. , Thumboo J. Singapore General Hospital, Outram, Singapore Objectives: This study aims to identify the care needs for rheumatoid arthritis (RA) from patient perspectives. MethOds: One-on-one in-depth interviews were conducted with selected patients with RA in March 2014 in Singapore General Hospital as part of a larger ongoing study. The interviews were performed by a trained sociologist following an interview guide allowing free probes. Each Interview lasted for 20-60 minutes. 16 interviews were audio-recorded and transcribed with written consent from the patients. Notes were taken for the three unrecorded interviews. The transcripts and notes were analysed using NVivo 10 to identify major areas of patient-reported care needs. Results: 19 patients (11 Chinese, 2 Malays, and 6 Indians; 17 females; age: 25-67 years; median educational level: higher secondary school) with 1-38 years of RA were interviewed. 15 had accepted that they would need lifelong RA medication; three were still testing if they could live without medication through self-experimentation; and one was in denial of the diagnosis. In additional to medical treatment, three other areas of care needs were identified: first, the need for knowledge about RA and its self-management (n= 17) ; second, the need for peer support to learn "how other people live with RA" (n= 11); and third, the need for psycho-emotional support to manage the emotional problems accompanying RA diagnosis (n= 9). These needs were most acute upon diagnosis and became less important once the patient had established new normality of life after having RA (e.g. avoiding things one cannot do due to RA without feeling bad, taking RA medication without feeling being hassled). cOnclusiOns: The results of this study suggest that RA patients' care needs are multidimensional and time sensitive. A muti-pronged approach including drug therapy, and patient education, support, and counselling is needed from start of treatment to help patients form the new normality of their lives. PMs25 suitaBility research on the evaluation of eq-5q anD sf-6D scale for the quality of life in Patients With osteoarthritis Fang Z Shenyang Pharmaceutical University, Shenyang, China Objectives: As the universal scales, EQ-5D and SF-6D have been widely used in the evaluation of the quality of life(QOL) of patients with many kinds of disease including Osteoarthritis. But as to which scale is much more suitable for the Osteoarthritis patients evaluation , there is scarcely any research so far. The current study aimed to compare the correlation of the EQ -5D, SF-6D with AIMS2-2F scale, the specificity scale of QOL evaluation, then to determine the suitability of two scale for the QOL of patients with Osteoarthritis. MethOds: From April to December in 2012, 100 patients with Osteoarthritis were enrolled with consent at Orthopedic Clinic in the First Affiliated Hospital of Chinese Medical University. They filled out the EQ-5D, SF-6D, and AIMS2 2F scales successively by themselves . SPSS19.0 analysis software was used to deal with the collected data, parts of the lack data were eliminated automatically . Cronbach alpha coefficient evaluated the internal consistency of scales. Pearson, Speaman and Kendall's tau-b correlation coefficient analysis were used to test the reliability between EQ-5D, SF-6D and AIMS2-2F score data. On the scale of the response and the factors affecting the QOL, we use multiple stepwise regression analysis, significant test of bilateral boundary value point. Results: 77 sets of valid survey scale were analyst EQ-5D, SF-6D, and AIMS2-2F scales all had good internal consistency showing good reliability with the crowns Bach coefficient were all higher than 0.6.During the various dimensions of EQ-5D scale, Anxiety, Pain, Daily life and Self care showed the higher sensitivity on AIMS2-2F scale. Followed by Ability to act . As to SF-6D scale, Psychological health, Vitality, and Social function showed higher sensitivity on AIMS2-2F scale. And followed by Role constraints, Pain and Physical func-
